Skip to main content
Clinical Trials/DRKS00014049
DRKS00014049CompletedNot Applicable

Comparison of bioactive glass S53P4 as bone graft substitute and autologous bone graft in the treatment of chronic osteomyelitis and infected non-unions – a comparative retrospective study - Bioactive glass versus autologous bone graft in osteomyelitis

BG Klinikum Duisburg0 sites95 target enrollmentStarted: February 26, 2018Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
95

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to 99 Years (—)
Sex
All

Inclusion Criteria

  • Chronic osteomyelitis and/ or infected non-union
  • - Filling of the bony defect with either autologous bone graft or bioactive glass S53P4
  • - Follow-up at a minimum of 12 months

Exclusion Criteria

  • - Aseptic non-union
  • - Follow-up < 12 months

Investigators

Sponsor
BG Klinikum Duisburg

Similar Trials

Comparison of bioactive glass S53P4 as... | Clinical Trial